These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9781928)
1. Relationships between heart rate and heart rate variability: study in conscious rats. Mangin L; Swynghedauw B; Benis A; Thibault N; Lerebours G; Carré F J Cardiovasc Pharmacol; 1998 Oct; 32(4):601-7. PubMed ID: 9781928 [TBL] [Abstract][Full Text] [Related]
2. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats. Gardiner SM; Kemp PA; March JE; Bennett T Br J Pharmacol; 1995 Jun; 115(4):579-86. PubMed ID: 7582475 [TBL] [Abstract][Full Text] [Related]
3. Modulation of sympathetic activity and heart rate variability by ivabradine. Dias da Silva VJ; Tobaldini E; Rocchetti M; Wu MA; Malfatto G; Montano N; Zaza A Cardiovasc Res; 2015 Oct; 108(1):31-8. PubMed ID: 26101263 [TBL] [Abstract][Full Text] [Related]
4. Novel If current inhibitor ivabradine: safety considerations. Savelieva I; Camm AJ Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474 [TBL] [Abstract][Full Text] [Related]
5. Ivabradine improves heart rate variability in patients with nonischemic dilated cardiomyopathy. Kurtoglu E; Balta S; Karakus Y; Yasar E; Cuglan B; Kaplan O; Gozubuyuk G Arq Bras Cardiol; 2014 Oct; 103(4):308-14. PubMed ID: 25119894 [TBL] [Abstract][Full Text] [Related]
6. Reevaluation of arrhythmias and alterations of the autonomic nervous activity induced by T-2 toxin through telemetric measurements in unrestrained rats. Ngampongsa S; Ito K; Kuwahara M; Ando K; Tsubone H Toxicol Mech Methods; 2012 Nov; 22(9):662-73. PubMed ID: 22853741 [TBL] [Abstract][Full Text] [Related]
7. The bradycardic agent zatebradine enhances baroreflex sensitivity and heart rate variability in rats early after myocardial infarction. Krüger C; Landerer V; Zugck C; Ehmke H; Kübler W; Haass M Cardiovasc Res; 2000 Mar; 45(4):900-12. PubMed ID: 10728416 [TBL] [Abstract][Full Text] [Related]
8. Cardioprotection by ivabradine through heart rate reduction and beyond. Heusch G; Skyschally A; Schulz R J Cardiovasc Pharmacol Ther; 2011; 16(3-4):281-4. PubMed ID: 21821529 [TBL] [Abstract][Full Text] [Related]
9. Periodic variation in R-R intervals and cardiovascular autonomic regulation in young adult Syrian hamsters. Mongue-Din H; Salmon A; Fiszman MY; Fromes Y Am J Physiol Regul Integr Comp Physiol; 2009 Mar; 296(3):R610-7. PubMed ID: 19109374 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers. Ragueneau I; Laveille C; Jochemsen R; Resplandy G; Funck-Brentano C; Jaillon P Clin Pharmacol Ther; 1998 Aug; 64(2):192-203. PubMed ID: 9728900 [TBL] [Abstract][Full Text] [Related]
11. The effect of sinus node depression on heart rate variability in humans using zatebradine, a selective bradycardic agent. Khaykin Y; Dorian P; Tang A; Green M; Mitchell J; Wulffhart Z; Newman D Can J Physiol Pharmacol; 1998; 76(7-8):806-10. PubMed ID: 10030463 [TBL] [Abstract][Full Text] [Related]
12. Three different bradycardic agents, zatebradine, diltiazem and propranolol, distinctly modify heart rate variability and QT-interval variability. Yamabe M; Sanyal SN; Miyamoto S; Hadama T; Isomoto S; Ono K Pharmacology; 2007; 80(4):293-303. PubMed ID: 17690562 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive method for electrocardiogram recording in conscious rats: feasibility for heart rate variability analysis. Pereira-Junior PP; Marocolo M; Rodrigues FP; Medei E; Nascimento JH An Acad Bras Cienc; 2010 Jun; 82(2):431-7. PubMed ID: 20563424 [TBL] [Abstract][Full Text] [Related]
14. Dominant Parasympathetic Modulation of Heart Rate and Heart Rate Variability in a Wild-Caught Seabird. Carravieri A; Müller MS; Yoda K; Hayama S; Yamamoto M Physiol Biochem Zool; 2016; 89(4):263-76. PubMed ID: 27327178 [TBL] [Abstract][Full Text] [Related]
15. The relationship between respiratory sinus arrhythmia and heart rate during anesthesia in rat. Moldovan M; Spulber S; Saravan V; Iosifescu R; Zăgrean AM; Zăgrean L Rom J Physiol; 2004; 41(1-2):31-9. PubMed ID: 15984654 [TBL] [Abstract][Full Text] [Related]
16. Pacemaker current inhibition in experimental human cardiac sympathetic activation: a double-blind, randomized, crossover study. Schroeder C; Heusser K; Zoerner AA; Großhennig A; Wenzel D; May M; Sweep FC; Mehling H; Luft FC; Tank J; Jordan J Clin Pharmacol Ther; 2014 Jun; 95(6):601-7. PubMed ID: 24509430 [TBL] [Abstract][Full Text] [Related]
17. Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. Joannides R; Moore N; Iacob M; Compagnon P; Lerebours G; Menard JF; Thuillez C Br J Clin Pharmacol; 2006 Feb; 61(2):127-37. PubMed ID: 16433867 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats. Riesen SC; Schober KE; Cervenec RM; Bonagura JD J Vet Intern Med; 2011; 25(3):469-76. PubMed ID: 21418320 [TBL] [Abstract][Full Text] [Related]
19. Right atrium cholinergic deficit in septic rats. Contreras P; Migliaro ER; Suhr B Auton Neurosci; 2014 Feb; 180():17-23. PubMed ID: 24269487 [TBL] [Abstract][Full Text] [Related]
20. Time-domain evaluation of cyclosporine interaction with hemodynamic variability in rats. Omar AG; El-Mas MM Cardiovasc Drugs Ther; 2004 Nov; 18(6):461-8. PubMed ID: 15770433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]